PSA founding father honoured for lifetime’s work
The 'founder', 'prime innovator' and 'driving force' behind the establishment of the PSA, Ross Brown FPS, has been honoured with the association's Lifetime Achievement...
Five ways to address gaps in rural and remote healthcare
More than 1.3 million Australians in rural and remote areas do not take their medicines at all or as intended, according to a new report from PSA.
Does NRT work for everyone?
While effective for many, smoking cessation strategies – including NRT – are not a one-size-fits-all approach.
Vale Prof Gabrielle Cooper OAM (1962 to 2025)
PSA is saddened to learn of the passing of Professor Gabrielle Cooper OAM, who died on 23 April after a short illness.
PSA demands equity of healthcare access for Aboriginal and Torres Strait...
From changes to policy, service design and delivery, PSA calls for action to improve Aboriginal and Torres Strait Islander healthcare.
Short-acting beta₂ agonists (salbutamol and terbutaline)
The PSA guidance document Guidance for provision of a Pharmacist Only medicine–Short-acting beta₂ agonists (salbutamol and terbutaline)2 assists in responding appropriately to a request...
